After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
EXAS belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Exact Sciences Corp. is $12.27B. A total of 1.51 million shares were traded on the day, compared to an average of 2.63M shares.
In the most recent transaction, Baranick Brian sold 929 shares of EXAS for 70.00 per share on Sep 18 ’24. After the transaction, the EVP, GM, Precision Oncology now owns 13,687 company shares. In a previous transaction on Sep 18 ’24, Baranick Brian bought 929 shares at 70.00 per share.
Among the insiders who sold shares, COWARD D SCOTT disposed of 67 shares on May 01 ’24 at a per-share price of $60.15. This resulted in the Director holding 44,644 shares of EXAS after the transaction. In another insider transaction, Cunningham Everett sold 136 shares at $60.15 per share on May 01 ’24. Company shares held by the Chief Commercial Officer now total 47,042.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EXAS has a high of $79.62 and a low of $40.62.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EXAS’s latest balance sheet shows that the firm has $1.03B in Cash & Short Term Investments as of fiscal 2021. There were $2.38B in debt and $517.07M in liabilities at the time. Its Book Value Per Share was $17.29, while its Total Shareholder’s Equity was $3.39B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXAS is Buy with a score of 4.73.
